Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05763732 · ClinicalTrials.gov registry record · NA

Effects of RAS on Gait in PD Patients With DBS

A NA study of Parkinson Disease, sponsored by Johns Hopkins University.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT05763732 is a NA study of Parkinson Disease that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 10 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05763732, a NA study of Parkinson Disease, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

Participants will be asked to walk along with the metronome beats (RAS) during the participants' stimulation state (ON or OFF) for four minutes for each state. The researcher will collect the gait parameters (cadence, velocity, and stride length) of patients before, during, and after RAS in both DBS ON and OFF states. Using MDS-UPDRS, participants' gait patterns will be collected before and after RAS while both DBS is ON and OFF. Electrophysiological activity (local field potentials, LFPs) will be collected across all stages (pre, during, and post-RAS) of evaluation.

Conditions Studied

Interventions

  • BEHAVIORAL Rhythmic Auditory Stimulation (RAS)

Study Locations (1)

Maryland

  • Johns Hopkins School of Medicine - Baltimore

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2023-08-01
Est. Completion 2026-04
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT05763732

The ClinicalTrials.gov registry entry for NCT05763732 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Rhythmic Auditory Stimulation (RAS) is the first listed.

NCT05763732 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT05763732 about?

NCT05763732 is a clinical study titled "Effects of RAS on Gait in PD Patients With DBS". Participants will be asked to walk along with the metronome beats (RAS) during the participants' stimulation state (ON or OFF) for four minutes for each state. The researcher will collect the gait parameters (cadence, velocity, and stride length) of patients before, during, and after RAS in both DB...

What is the current status of trial NCT05763732?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2023-08-01. Estimated completion is 2026-04.

What conditions does trial NCT05763732 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT05763732?

The interventions under investigation include: Rhythmic Auditory Stimulation (RAS) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05763732?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05763732 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.